InspireMD (NSPR) News Today $2.59 -0.10 (-3.72%) (As of 12:07 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.comStockNews.com began coverage on shares of InspireMD in a research note on Saturday. They set a "sell" rating for the company.December 28 at 2:17 AM | marketbeat.comInspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.comStockNews.com began coverage on InspireMD in a report on Friday. They issued a "sell" rating for the company.December 20, 2024 | marketbeat.comInspireMD, Inc.: InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025December 12, 2024 | finanznachrichten.deInspireMD Finance Chief Craig Shore To RetireDecember 12, 2024 | markets.businessinsider.comInspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025December 12, 2024 | finance.yahoo.comLake Street Initiates Coverage of InspireMD (NSPR) with Buy RecommendationDecember 12, 2024 | msn.comInspireMD (NYSE:NSPR) Now Covered by StockNews.comStockNews.com started coverage on shares of InspireMD in a report on Thursday. They issued a "sell" rating for the company.December 12, 2024 | marketbeat.comInspireMD initiated with a Buy at Lake StreetDecember 11, 2024 | markets.businessinsider.comInspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)December 9, 2024 | globenewswire.comInspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of DirectorsNovember 26, 2024 | finance.yahoo.comInspireMD (NYSE:NSPR) Coverage Initiated at StockNews.comStockNews.com began coverage on shares of InspireMD in a research note on Tuesday. They set a "sell" rating on the stock.November 26, 2024 | marketbeat.comInspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of DirectorsNovember 25, 2024 | globenewswire.comInspireMD, Inc. (II2.F)November 21, 2024 | nz.finance.yahoo.comInspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comInspireMD Inc. Reports Q3 2024 Financial ResultsNovember 13, 2024 | markets.businessinsider.comInspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ...November 13, 2024 | finance.yahoo.comInspireMD Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 12, 2024 | markets.businessinsider.comWhat To Expect From InspireMD Inc (NSPR) Q3 2024 EarningsNovember 11, 2024 | finance.yahoo.comStockNews.com Begins Coverage on InspireMD (NYSE:NSPR)StockNews.com initiated coverage on InspireMD in a research note on Sunday. They set a "sell" rating for the company.November 10, 2024 | marketbeat.comInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 8, 2024 | globenewswire.comInspireMD (NSPR) Set to Announce Earnings on TuesdayInspireMD (NYSE:NSPR) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comInspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12thNovember 4, 2024 | finance.yahoo.comInspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.comStockNews.com initiated coverage on InspireMD in a report on Friday. They issued a "sell" rating on the stock.October 25, 2024 | marketbeat.comOne InspireMD Insider Raised Stake By 13% In Previous YearOctober 22, 2024 | finance.yahoo.comInspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent SystemOctober 15, 2024 | globenewswire.comInspireMD Inc (NSPR) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ChallengesOctober 9, 2024 | finance.yahoo.comInspireMD (NYSE:NSPR) Research Coverage Started at StockNews.comStockNews.com initiated coverage on shares of InspireMD in a research note on Wednesday. They issued a "sell" rating for the company.October 9, 2024 | marketbeat.comInspireMD Advances with FDA Study Approval and Global GoalsOctober 8, 2024 | finance.yahoo.comInspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent SystemOctober 7, 2024 | globenewswire.comStockNews.com Initiates Coverage on InspireMD (NYSE:NSPR)StockNews.com started coverage on shares of InspireMD in a research note on Tuesday. They set a "sell" rating on the stock.October 1, 2024 | marketbeat.comInspireMD (NSPR) Receives a Buy from Piper SandlerSeptember 18, 2024 | markets.businessinsider.comInspireMD (NYSE:NSPR) Given Overweight Rating at Piper SandlerPiper Sandler reissued an "overweight" rating and set a $4.50 price objective on shares of InspireMD in a research report on Tuesday.September 17, 2024 | marketbeat.comInspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent SystemSeptember 16, 2024 | globenewswire.comInvestors in InspireMD (NASDAQ:NSPR) have unfortunately lost 88% over the last five yearsSeptember 14, 2024 | finance.yahoo.comInspireMD, Inc. (NSPR) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comNexstar Media GAAP EPS of $3.54 misses by $0.11, revenue of $1.27B misses by $10MAugust 8, 2024 | msn.comInspireMD, Inc.: InspireMD Congratulates CREST-2 Investigators on Completion of Trial EnrollmentAugust 7, 2024 | finanznachrichten.deR1 RCM Reports Second Quarter 2024 ResultsAugust 7, 2024 | markets.businessinsider.comCompanies Like InspireMD (NASDAQ:NSPR) Are In A Position To Invest In GrowthAugust 7, 2024 | finance.yahoo.comInspireMD, Inc.: InspireMD Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 6, 2024 | finanznachrichten.deInspireMD Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 6, 2024 | finance.yahoo.comInspireMD Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 6, 2024 | globenewswire.comInspireMD Congratulates CREST-2 Investigators on Completion of Trial EnrollmentAugust 5, 2024 | globenewswire.comInspireMD (NSPR) Scheduled to Post Quarterly Earnings on TuesdayInspireMD (NYSE:NSPR) will be releasing earnings before the market opens on Tuesday, August 6, Zacks reports.July 31, 2024 | marketbeat.comInspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6thJuly 30, 2024 | globenewswire.comInspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024May 28, 2024 | globenewswire.comInspireMD (NYSE:NSPR) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPSInspireMD (NYSE:NSPR - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.06). The company had revenue of $1.51 million during the quarter, compared to the consensus estimate of $1.38 million. InspireMD had a negative net margin of 320.97% and a negative return on equity of 55.71%. During the same period in the prior year, the company posted ($0.53) EPS.May 15, 2024 | marketbeat.comInspireMD earnings preview: what Wall Street is expectingMay 15, 2024 | markets.businessinsider.comNSPR Stock Earnings: InspireMD Misses EPS, Beats Revenue for Q1 2024May 14, 2024 | investorplace.comInspireMD Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | globenewswire.com Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Altcoin season moves fast, and those who hesitate are left behind. The window is closing. >> Register for the Workshop Now NSPR Media Mentions By Week NSPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NSPR News Sentiment▼0.590.59▲Average Medical News Sentiment NSPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NSPR Articles This Week▼11▲NSPR Articles Average Week Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMTI News Today CVRX News Today ZYXI News Today ELMD News Today LUNG News Today CATX News Today DRTS News Today PROF News Today NYXH News Today KRMD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NSPR) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersTrading 5-7 Stocks to Profit $1,300 a Day?If you want a straightforward, faster, and potentially more reliable way to trade… Learn this strategy by w...Prosper Trading Academy | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberr...Porter & Company | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredFastest Way To Build Wealth From Trump Stock MELT UPDonald Trump is about to ignite the biggest… and fastest… stock market boom in American history. He will be...Banyan Hill Publishing | SponsoredElon Musk’s next tweet could help pay for your retirementElon Musk says the government is going bankrupt. Seniors are getting crushed by inflation.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
